UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 16,826 Shares of TriMas Co. (NASDAQ:TRS)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of TriMas Co. (NASDAQ:TRS - Free Report) by 18.5% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 107,806 shares of the industrial products company's stock after purchasing an additional 16,826 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.27% of TriMas worth $2,651,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Sterling Capital Management LLC increased its position in TriMas by 815.5% during the fourth quarter. Sterling Capital Management LLC now owns 1,300 shares of the industrial products company's stock worth $32,000 after buying an additional 1,158 shares during the last quarter. State of Wyoming acquired a new position in shares of TriMas during the 4th quarter worth approximately $50,000. KLP Kapitalforvaltning AS bought a new stake in TriMas in the 4th quarter valued at $202,000. ProShare Advisors LLC acquired a new stake in TriMas during the 4th quarter valued at $281,000. Finally, Quantbot Technologies LP lifted its holdings in TriMas by 203.5% during the 4th quarter. Quantbot Technologies LP now owns 11,978 shares of the industrial products company's stock valued at $295,000 after purchasing an additional 8,031 shares during the last quarter. Institutional investors own 99.42% of the company's stock.

Insiders Place Their Bets

In other news, Director Shawn Sedaghat purchased 123,388 shares of the business's stock in a transaction dated Wednesday, April 30th. The stock was bought at an average price of $23.83 per share, with a total value of $2,940,336.04. Following the acquisition, the director now owns 1,024,362 shares in the company, valued at approximately $24,410,546.46. The trade was a 13.69% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders have purchased a total of 1,520,598 shares of company stock worth $37,788,858 in the last 90 days. Company insiders own 14.20% of the company's stock.

TriMas Stock Performance

TRS opened at $25.67 on Friday. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.83 and a quick ratio of 1.44. The business has a fifty day simple moving average of $23.40 and a 200 day simple moving average of $24.03. TriMas Co. has a 1 year low of $19.33 and a 1 year high of $28.51. The company has a market capitalization of $1.04 billion, a PE ratio of 40.11 and a beta of 0.58.

TriMas (NASDAQ:TRS - Get Free Report) last posted its earnings results on Tuesday, April 29th. The industrial products company reported $0.46 earnings per share for the quarter, topping analysts' consensus estimates of $0.43 by $0.03. TriMas had a return on equity of 9.21% and a net margin of 2.93%. The company had revenue of $241.67 million during the quarter, compared to the consensus estimate of $235.41 million. During the same quarter last year, the firm earned $0.37 earnings per share. The company's revenue was up 6.4% on a year-over-year basis. Research analysts expect that TriMas Co. will post 1.69 EPS for the current year.

TriMas Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, May 13th. Investors of record on Tuesday, May 6th were given a dividend of $0.04 per share. This represents a $0.16 dividend on an annualized basis and a yield of 0.62%. The ex-dividend date was Tuesday, May 6th. TriMas's dividend payout ratio is currently 20.78%.

Analyst Ratings Changes

Several brokerages have recently weighed in on TRS. Wall Street Zen raised shares of TriMas from a "hold" rating to a "buy" rating in a research report on Sunday, June 1st. BWS Financial restated a "buy" rating and set a $40.00 price objective on shares of TriMas in a research report on Wednesday, April 30th.

About TriMas

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.

Want to see what other hedge funds are holding TRS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TriMas Co. (NASDAQ:TRS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.